Investing in the lives of world's poorest children

in page functions

Pioneered in 2006, the International Finance Facility for Immunisation (IFFIm) builds a financial lifeline from the world's richest investors to its poorest children.

IFFIm 4

IFFIm converts government pledges into immediately available funding for GAVI by issuing 'vaccine bonds' in capital markets. 'Predictable', secure support encourages developing countries to invest in long-term  immunisation programmes.

IFFIm 2
Jay Louvion/GAVI/08

Under the leadership of IFFIm Board chairman Alan Gillespie, IFFIm has attracted US$ 6.2 billion in donor commitments over 23 years. IFFIm provides a flexible funding alternative for donors, especially those that are not able to provide large  direct grants.

IFFIm 11
Photographic Service L'Osservatore Romano/09

Former UK Premier Gordon Brown, who helped pioneer IFFIm, visits Pope Benedict XVI to commemorate the Vatican’s purchase of the first vaccine bond in 2006. IFFIm has raised US$ 3.2 billion in bond sales in the UK, Japan and Australia.

IFFIm 3
Dan Thomas/GAVI/09

With a triple-A rating, IFFIm promises investors like Keiko Aoshima a solid return. “With other bonds, you never really know how your money will be used, but this investment will be used for human good."

IFFIm 8
Dominic Chavez/GAVI/08

Thanks to IFFIm funds, GAVI has effectively doubled its spending on immunisation and health system strengthening programmes since 2006.

IFFIm 6
Edy Purnomo/GAVI/07

IFFIm’s long-term funding acts as an incentive for the vaccine industry to invest the large sums of money necessary to develop and manufacture appropriate vaccines for poorer countries. 

IFFIm 5
Olivier Asselin/GAVI/08

It also gives Health Ministries in developing countries confidence to make long-term investments in immunisation programmes, such as strengthening vaccine delivery systems or training health workers.  

IFFIm 9
Olivier Asselin/GAVI/08

Mothers at the Barumbu Mother & Child Centre in Kinshasa in DR Congo discuss immunisation with a health worker. In 2007, GAVI channelled US$ 88.3 million of IFFIm funds into strengthening health systems.  

IFFIm 7
Olivier Asselin/GAVI/09

The availability of IFFIm funds to support the introduction of the five-in-one pentavalent vaccine until 2015 is encouraging new manufacturers to enter the market. 

IFFIm 10
Olivier Asselin/WHO/08

A young boy is vaccinated against yellow fever in Togo, one of 1.3 million people targeted in an emergency immunisation campaign.  In 2007, IFFIm funds helped build up a regional stockpile of yellow fever vaccine for west African countries.

IFFIm 1
Olivier Asselin/GAVI/09

The IFFIm model has "successfully demonstrated a proof of concept, proven to be financially efficient ... achieved supranational status in the capital markets." Independent evaluation of IFFIm, June 2011.

close icon

modal window here